Literature DB >> 21777678

Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6.

Abdellahi Ould M'hamed Ould Sidi1, Khaled Ould Babah, Nicole Brimer, Yves Nominé, Christophe Romier, Bruno Kieffer, Scott Vande Pol, Gilles Travé, Katia Zanier.   

Abstract

E6 is a small oncoprotein involved in tumorigenesis induced by papillomaviruses (PVs). E6 often recognizes its cellular targets by binding to short motifs presenting the consensus LXXLL. E6 proteins have long resisted structural analysis. We found that bovine papillomavirus type 1 (BPV1) E6 binds the N-terminal LXXLL motif of the cellular protein paxillin with significantly higher affinity as compared to other E6/peptide interactions. Although recombinant BPV1 E6 was poorly soluble in the free state, provision of the paxillin LXXLL peptide during BPV1 E6 biosynthesis greatly enhanced the protein's solubility. Expression of BPV1 E6/LXXLL peptide complexes was carried out in bacteria in the form of triple fusion constructs comprising, from N- to C-terminus, the soluble carrier protein maltose binding protein (MBP), the LXXLL motif and the E6 protein. A TEV protease cleavage site was placed either between MBP and LXXLL motif or between LXXLL motif and E6. These constructs allowed us to produce highly concentrated samples of BPV1 E6, either covalently fused to the C-terminus of the LXXLL motif (intra-molecular complex) or non-covalently bound to it (inter-molecular complex). Heteronuclear NMR measurements were performed and showed that the E6 protein was folded with similar conformations in both covalent and non-covalent complexes. These data open the way to novel structural and functional studies of the BPV1 E6 in complex with its preferential target motif.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777678      PMCID: PMC3183320          DOI: 10.1016/j.pep.2011.06.013

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  31 in total

1.  A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein.

Authors:  Y Nominé; T Ristriani; C Laurent; J F Lefèvre; G Travé
Journal:  Protein Eng       Date:  2001-04

2.  Domain substructure of HPV E6 oncoprotein: biophysical characterization of the E6 C-terminal DNA-binding domain.

Authors:  Yves Nominé; Sebastian Charbonnier; Tutik Ristriani; Gunter Stier; Murielle Masson; Nukhet Cavusoglu; Alain Van Dorsselaer; Etienne Weiss; Bruno Kieffer; Gilles Travé
Journal:  Biochemistry       Date:  2003-05-06       Impact factor: 3.162

Review 3.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

Review 4.  Papillomaviruses in human cancers.

Authors:  H zur Hausen
Journal:  Proc Assoc Am Physicians       Date:  1999 Nov-Dec

5.  Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP.

Authors:  K Das; J Bohl; S B Vande Pol
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Formation of soluble inclusion bodies by hpv e6 oncoprotein fused to maltose-binding protein.

Authors:  Y Nominé; T Ristriani; C Laurent; J F Lefèvre; G Travé
Journal:  Protein Expr Purif       Date:  2001-10       Impact factor: 1.650

7.  Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein.

Authors:  J Bohl; K Das; B Dasgupta; S B Vande Pol
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

8.  Chelating agents stabilize the monomeric state of the zinc binding human papillomavirus 16 E6 oncoprotein.

Authors:  Roland Degenkolbe; Patrick Gilligan; Sanjay Gupta; Hans U Bernard
Journal:  Biochemistry       Date:  2003-04-08       Impact factor: 3.162

9.  Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein.

Authors:  F Lipari; G A McGibbon; E Wardrop; M G Cordingley
Journal:  Biochemistry       Date:  2001-02-06       Impact factor: 3.162

Review 10.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

View more
  9 in total

1.  A semi-automated method for purification of milligram quantities of proteins on the QIAcube.

Authors:  J McGraw; V K Tatipelli; O Feyijinmi; M C Traore; P Eangoor; S Lane; E J Stollar
Journal:  Protein Expr Purif       Date:  2014-02-05       Impact factor: 1.650

2.  Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.

Authors:  Katia Zanier; Abdellahi ould M'hamed ould Sidi; Charlotte Boulade-Ladame; Vladimir Rybin; Anne Chappelle; Andrew Atkinson; Bruno Kieffer; Gilles Travé
Journal:  Structure       Date:  2012-04-03       Impact factor: 5.006

3.  Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.

Authors:  Katia Zanier; Sebastian Charbonnier; Abdellahi Ould M'hamed Ould Sidi; Alastair G McEwen; Maria Giovanna Ferrario; Pierre Poussin-Courmontagne; Vincent Cura; Nicole Brimer; Khaled Ould Babah; Tina Ansari; Isabelle Muller; Roland H Stote; Jean Cavarelli; Scott Vande Pol; Gilles Travé
Journal:  Science       Date:  2013-02-08       Impact factor: 47.728

4.  Mutagenic Potential ofBos taurus Papillomavirus Type 1 E6 Recombinant Protein: First Description.

Authors:  Rodrigo Pinheiro Araldi; Jacqueline Mazzuchelli-de-Souza; Diego Grando Modolo; Edislane Barreiros de Souza; Thatiana Corrêa de Melo; Diva Denelle Spadacci-Morena; Roberta Fiusa Magnelli; Márcio Augusto Caldas Rocha de Carvalho; Paulo Luis de Sá Júnior; Rodrigo Franco de Carvalho; Willy Beçak; Rita de Cassia Stocco
Journal:  Biomed Res Int       Date:  2015-12-09       Impact factor: 3.411

5.  One-step affinity purification of fusion proteins with optimal monodispersity and biological activity: application to aggregation-prone HPV E6 proteins.

Authors:  Anna Bonhoure; Auguste Demenge; Camille Kostmann; Leticia San José; Eva De la Cal; Pilar Armisen; Yves Nominé; Gilles Travé
Journal:  Microb Cell Fact       Date:  2018-12-01       Impact factor: 5.328

6.  Expression and in Silico analysis of the recombinant bovine papillomavirus E6 protein as a model for viral oncoproteins studies.

Authors:  J Mazzuchelli-de-Souza; R F Carvalho; R M Ruiz; T C Melo; R P Araldi; E Carvalho; C E Thompson; M P Sircili; W Beçak; R C Stocco
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

7.  Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.

Authors:  Jonathan J Cherry; Anne Rietz; Anna Malinkevich; Yuqi Liu; Meng Xie; Matthew Bartolowits; V Jo Davisson; James D Baleja; Elliot J Androphy
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 8.  Structural Insights in Multifunctional Papillomavirus Oncoproteins.

Authors:  Irina Suarez; Gilles Trave
Journal:  Viruses       Date:  2018-01-15       Impact factor: 5.048

9.  Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model.

Authors:  Alex Allen; Chuan Wang; Lisa J Caproni; Gessa Sugiyarto; Elena Harden; Leon R Douglas; Patrick J Duriez; Kinga Karbowniczek; Jon Extance; Paul J Rothwell; Ifeayinwa Orefo; John P Tite; Freda K Stevenson; Christian H Ottensmeier; Natalia Savelyeva
Journal:  Cancer Immunol Immunother       Date:  2018-01-12       Impact factor: 6.968

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.